Intel Capital chipped in as part of a series B round set to drive product development and growth for food supply insights provider Gro Intelligence.

Echo Health Ventures has joined Arkansas Blue Cross Blue Shield's investment arm in a strategic initiative aimed at scaling up healthcare businesses.

The Sinopharm and WuXi AppTec-backed, complement system-focused drug developer has hauled in $53.3m of new funding after emerging from stealth late last year.

McClatchy, Gannett and Tonc have exited the gig-economy recruitment platform in an acquisition by peer CareerGig.

The transistor technology developer has disclosed $21.8m in series A funding from investors including Agilent Technologies across three tranches.

American Family’s venture capital unit has contributed to a $22.5m round that will support the digital mortgage lender's US expansion.

Weber has bought the smart oven producer, one of its portfolio companies, in a deal that allows Amazon Alexa Fund to exit.

Weill Cornell Medicine‘s monogenic diseases therapy developer Lexeo Therapeutics has made its public debut with $85m in series A financing.

Genomic drug developer Tessera Therapeutics raised $230m in a round co-led by SoftBank Vision Fund 2 as it works on its gene writing technology.

Corning and SoftBank-backed dynamic glass producer View's previously announced reverse merger will be boosted by $200m from Singapore's sovereign wealth fund.